from Your News:
New findings reveal that Pfizer failed to disclose two participant deaths during clinical trials for its COVID-19 vaccine, sparking renewed scrutiny over the company’s transparency and the approval process for its mRNA vaccine.
By yourNEWS Media Newsroom
Pharmaceutical giant Pfizer did not report two deaths that occurred during its COVID-19 vaccine trials prior to the vaccine’s emergency-use authorization in December 2020, according to Daily Clout researchers. Both deaths, classified as “sudden cardiac death,” were omitted from critical disclosures made to the FDA and in publications touting the vaccine’s safety and efficacy.
TRUTH LIVES on at https://sgtreport.tv/
The deceased trial participants included a 63-year-old woman from Kansas and a 58-year-old woman from Georgia. Pfizer’s internal documents reportedly show a delay of 37 days in reporting the Kansas woman’s autopsy results, which occurred before the trial’s data cutoff on November 14, 2020. Neither death was disclosed to the FDA’s Vaccines and Related Biological Products Advisory Committee before their December 10 meeting, nor were they included in a December 2020 New England Journal of Medicine article praising the vaccine.
The revelations prompted Dr. Jeyanthi Kunadhasan — an Australian anesthesiologist and perioperative physician and one of the researchers analyzing the Pfizer documents on behalf of Daily Clout — to write to Kansas Attorney General Kris Kobach, requesting his office investigate the death of the 63-year-old Kansas woman.
“If the additional two deaths had been disclosed at the time of the EUA, it would have shown that the BNT162b2 mRNA COVID vaccine intervention provided no reduction in deaths,” Kunadhasan wrote in her letter.
Dr. Naomi Wolf, CEO of Daily Clout and author of The Pfizer Papers: Pfizer’s Crimes Against Humanity, accused the FDA of concealing the deaths. “These records may well reveal a direct connection to the mRNA injection,” she stated, adding that the omissions may have violated regulatory protocols.
Dr. Chris Flowers, who also reviewed the findings, emphasized the significance of the omissions, noting that such events typically lead to a pause in clinical trials. “Normally, the FDA calls a stop to those clinical trials until further investigation is done. And in many cases, [this] is sort of the death knell of that clinical trial,” he said.
A number of studies have since linked mRNA vaccines to rare but serious cardiac conditions, including myocarditis and pericarditis. Critics argue that early transparency could have influenced public health policies and vaccine distribution.
A recent study published in the Journal of American Physicians and Surgeons concluded that there is insufficient evidence to justify the continued use of mRNA vaccines, citing a growing body of adverse event data. Dr. Philip R. Oldfield, the study’s lead author, urged a halt to mRNA vaccines, stating, “Early on in the pandemic, we and other scientific bodies had been calling upon the government agencies to halt the mRNA shots. Every time, we were ignored. As more evidence is being accumulated, the truth is becoming more obvious.”
